Abstract:Sepsis-associated cerebral dysfunction is complex pathophysiology, generated from primary infections that are developed elsewhere in the body. The neonates, elderly population and chronically ill and long-term hospitalized patients are predominantly vulnerable to sepsis and related cerebral damage. Generally, electrophysiological recordings, severity and sedation scales, computerized imaging and spectroscopy techniques are used for its detection and diagnosis. About the underlying mechanisms, enhanced blood-brain barrier permeability and metalloprotease activity, tight junction protein loss and endothelial cell degeneration promote the influx of inflammatory and toxic mediators into the brain, triggering cerebrovascular damage. An altered neutrophil count and phenotype further dysregulate the normal neuroimmune responses and neuroendocrine stability via modulated activation of protein kinase C-delta, nuclear factor kappa-B and sphingolipid signaling. Glial activation, together with pro-inflammatory cytokines and chemokines and the Toll-like receptor, destabilize the immune system. Moreover, superoxides and hydroperoxides generate oxidative stress and perturb mitochondrial dynamics and ATP synthesis, propagating neuronal injury cycle. Activated mitochondrial apoptotic pathway, characterized by increased caspase-3 and caspase-9 cleavage and Bax/Bcl2 ratio in the hippocampal and cortical neurons, stimulate neurocognitive impairments. Additionally, altered LC3-II/I and P62/SQSTM1, p-mTOR, p-AMPK1 and p-ULK1 levels and dysregulated autophagosome-lysosome fusion decrease neuronal and glial energy homeostasis. The therapies and procedures for attenuating sepsis-induced brain damage include early resuscitation, cerebral blood flow autoregulation, implantable electric vagus nerve stimulation, antioxidants, statins, glucocorticoids, neuroimmune axis modulators and PKCδ inhibitors. The current review enumerates the pathophysiology of sepsis-induced brain damage, its diagnosis, the role of critical inducers and mediators and, ultimately, therapeutic measures attenuating cerebrovascular degeneration.

Sleep Disorders Have an Influence on Immune Function and the Development of Sepsis

Neuroendocrine immune network and sepsis

Bidirectional Interaction of Sepsis and Sleep Disorders: The Underlying Mechanisms and Clinical Implications

Sleep and Immune System Crosstalk: Implications for Inflammatory Homeostasis and Disease Pathogenesis

Sleep, Sleep Disorders, and Immune Function

The potential immunological mechanisms of sepsis

Sepsis triggered oxidative stress-inflammatory axis: the pathobiology of reprogramming in the normal sleep–wake cycle

Acute and long-term cognitive impairment following sepsis: mechanism and prevention

Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression

The significance and regulatory mechanisms of innate immune cells in the development of sepsis.

Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment

From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis

The Sleep-Immune Crosstalk in Health and Disease

Improvement in understanding of potential mechanism and immunomodulatory strategy for sepsis

Sleep and inflammation: partners in sickness and in health

The Significance and Regulatory Mechanisms of Innate Immune Cells in the Development of Sepsis

Sepsis-induced Immunosappression I Monitoring and Chanccenge

Sepsis and Cerebral Dysfunction: BBB Damage, Neuroinflammation, Oxidative Stress, Apoptosis and Autophagy as Key Mediators and the Potential Therapeutic Approaches

Immune dysfunction in the development of sepsis: from monitoring of immune status to immunomodulatory strategy

The role of the peripheral system dysfunction in the pathogenesis of sepsis-associated encephalopathy

Sepsis-associated encephalopathy: a vicious cycle of immunosuppression